The discovery of the HFE gene in 1996, the high prevalence of C282Y mutations, and the morbidity and mortality associated with untreated hereditary haemochromatosis have presented molecular diagnostics with a potentially attractive test for population screening. The gene discussed is HFE; the disease is hereditary hemochromatosis.